Stereotaxis, Inc.

Equities

STXS

US85916J4094

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 04:00:00 2024-07-17 pm EDT			5-day change	1st Jan Change
2.03 ^USD	-3.79%		+9.14%	+16.00%

Jul. 01	Stereotaxis, Inc.(NYSEAM:STXS) added to Russell Small Cap Comp Value Index	CI
Jul. 01	Stereotaxis, Inc.(NYSEAM:STXS) added to Russell Small Cap Completeness Index	CI

Sophrosyne Capital, LLC acquired 5.05% stake of Stereotaxis Inc..

January 11, 2013 at 12:00 am EST

Sophrosyne Capital, LLC acquired 5.05% stake of Stereotaxis Inc. (NasdaqGM:STXS) on January 11, 2013. Sophrosyne Capital purchased 0.4 million shares of Stereotaxis in this acquisition.

Sophrosyne Capital, LLC completed the acquisition of 5.05% stake of Stereotaxis Inc. (NasdaqGM:STXS) on January 11, 2013.

Latest news about Stereotaxis, Inc.

Stereotaxis, Inc.(NYSEAM:STXS) added to Russell Small Cap Comp Value Index	Jun. 30	CI
Stereotaxis, Inc.(NYSEAM:STXS) added to Russell Small Cap Completeness Index	Jun. 30	CI
Stereotaxis, Inc.(NYSEAM:STXS) added to Russell 2000 Index	Jun. 30	CI
Stereotaxis, Inc.(NYSEAM:STXS) added to Russell 3000E Index	Jun. 30	CI
Stereotaxis, Inc.(NYSEAM:STXS) added to Russell 3000 Growth Index	Jun. 30	CI
Stereotaxis, Inc.(NYSEAM:STXS) added to Russell 2500 Value Index	Jun. 30	CI
Stereotaxis, Inc.(NYSEAM:STXS) added to Russell 3000 Value Index	Jun. 30	CI
Stereotaxis, Inc.(NYSEAM:STXS) added to Russell 2000 Value Index	Jun. 30	CI
Stereotaxis, Inc.(NYSEAM:STXS) added to Russell 3000E Growth Index	Jun. 30	CI
Stereotaxis, Inc.(NYSEAM:STXS) added to Russell 2000 Growth Index	Jun. 30	CI
Stereotaxis, Inc.(NYSEAM:STXS) added to Russell 2000 Dynamic Index	Jun. 30	CI
Stereotaxis, Inc.(NYSEAM:STXS) added to Russell Microcap Value Index	Jun. 30	CI
Stereotaxis, Inc.(NYSEAM:STXS) added to Russell 2500 Growth Index	Jun. 30	CI
Stereotaxis, Inc.(NYSEAM:STXS) added to Russell Small Cap Comp Growth Index	Jun. 30	CI
Stereotaxis, Inc.(NYSEAM:STXS) added to Russell 2500 Index	Jun. 30	CI
Stereotaxis, Inc.(NYSEAM:STXS) added to Russell 3000 Index	Jun. 30	CI
Stereotaxis, Inc.(NYSEAM:STXS) added to Russell 3000E Value Index	Jun. 30	CI
Stereotaxis' Robotic Navigation System Used to Treat First Patients	May. 29	MT
Stereotaxis, Inc. Announces the Successful Treatment of the First Heart Rhythm Patients by Penn Presbyterian Medical Center Utilizing the Advanced Genesis Robotic Magnetic Navigation System	May. 29	CI
Stereotaxis Receives CE Mark Recertification in EU	May. 24	MT
Transcript : Stereotaxis, Inc., Q1 2024 Earnings Call, May 13, 2024	May. 13
Stereotaxis to Buy Access Point Technologies	May. 13	MT
Earnings Flash (STXS) STEREOTAXIS Reports Q1 Revenue $6.9M, vs. Street Est of $7.1M	May. 13	MT
Stereotaxis, Inc. Provides Revenue Guidance for the Full Year 2024	May. 13	CI
Stereotaxis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 13	CI

Chart Stereotaxis, Inc.

Duration

Period

More charts

Company Profile

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Companyâs primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-07 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Stereotaxis, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2.03 USD

Average target price

4.5 USD

Spread / Average Target

+121.67%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
STEREOTAXIS, INC.	+16.00%	167M
THERMO FISHER SCIENTIFIC	+4.57%	212B
DANAHER CORPORATION	+8.61%	186B
INTUITIVE SURGICAL, INC.	+26.34%	151B
BOSTON SCIENTIFIC CORPORATION	+33.90%	114B
SIEMENS HEALTHINEERS AG	+3.12%	65.57B
EDWARDS LIFESCIENCES CORPORATION	+14.50%	52.61B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-3.30%	46.8B
AGILENT TECHNOLOGIES, INC.	-3.98%	38.95B
GE HEALTHCARE TECHNOLOGIES INC.	+6.66%	37.64B

Other Advanced Medical Equipment & Technology